\
&
Contact us
\
&
Contact us
Published on | 6 years ago
ProgrammesIn the proposal of Horizon Europe, under Pillar II – “Global Challenges and Industrial Competiveness”, the Health cluster and its six intervention areas are described at an aggregated level (i.e. with no disease specifications, nor earmarked resources). This will be further detailed in the “strategic plan” and work programmes that are to be developed in a participatory manner.
All stakeholders, including civil society and the wider public, are invited to “Have your say on future objectives for EU-funded research and innovation” and contribute to the “strategic plan” and priorities of Horizon Europe’s first four years (2021-2024). You can participate by providing your input through the online survey (it takes approximately 20 minutes to respond). More information on the Commission’s proposal for Horizon Europe can be found here.
The before mentioned public online consultation will be open until the 6th of September 2019.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
